Question 1

Has Shraddha Mainali, MD received payments from drug or device companies?

Accepted Answer

Yes. Drug and device makers reported $120,503 in general payments to Shraddha Mainali, MD across 24 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Question 2

Does a payment mean Shraddha Mainali, MD did something wrong?

Accepted Answer

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Question 3

Where does this information about Shraddha Mainali, MD come from?

Accepted Answer

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Company	Payments	Total
AstraZeneca(2 entities)	7	$62,985
Portola Pharmaceuticals, LLC	12	$47,178
Immedica Pharma US, Inc.	4	$10,314
Novartis	1	$26

Shraddha Mainali, MD

Payments from drug & device makers

Who reported the general payments

How this compares

Medicare billing

Other neurology in Columbus